Comparability protocols: Final guidance incorporates ICH Q12, allows for API supplier changes
Regulatory NewsJoanne S. Eglovitch
APIsBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsProduct Lifecycle